Bone growth factors.

Bone volume is determined by the relative rates of bone formation and bone resorption. Recent research in several laboratories suggests that growth factors may act locally to modulate bone formation by stimulating osteoblast proliferation and activity. A number of bone-derived growth factors have been isolated and characterized from bone matrix extracts and from media conditioned by bone cells and bone organs in culture. The growth factors found in bone matrix include insulinlike growth factors I and II, transforming growth factor-beta, acidic and basic fibroblast growth factor, platelet-derived growth factor, and bone morphogenetic proteins. Conditioned medium from bone cells contains several of these growth factors and also hematopoietic factors. These bone matrix-derived growth factors have different biologic activities, including mitogenic, differentiating, chemotactic, and osteolytic activities. Evidence suggests that bone cells produce substantial quantities of growth factors for extracellular storage in bone matrix. Apart from being produced for extracellular storage, it is possible that growth factors secreted by bone cells have acute effects on their neighboring osteoblastic cells, i.e., paracrine action, or on themselves, i.e., autocrine action. The release of matrix-stored growth factors by bone resorption may mean that growth factors act as delayed paracrine agents, e.g., osteoblasts deposit growth factors in bone and later when these growth factors are released from bone via bone resorption, the growth factors stimulate osteoblast precursors to proliferate. The findings that bone is a storehouse for growth factors and that bone cells in culture produce and respond to bone growth factors suggest bone growth factors may act as potential determinants of local bone formation. This review is focused on the structure, regulation, and biologic actions of the known bone growth factors.

[1]  D. Moscatelli,et al.  The FGF family of growth factors and oncogenes. , 1992, Advances in cancer research.

[2]  E. Froesch,et al.  Insulin‐like growth factor I supports differentiation of cultured osteoblast‐like cells , 1984, FEBS letters.

[3]  C. Brinckerhoff,et al.  Use of agarose culture to measure the effect of transforming growth factor beta and epidermal growth factor on rabbit articular chondrocytes. , 1985, Cancer research.

[4]  M. Noda,et al.  In vivo stimulation of bone formation by transforming growth factor-beta. , 1989, Endocrinology.

[5]  L. Raisz,et al.  Local and systemic factors in the pathogenesis of osteoporosis. , 1988, World review of nutrition and dietetics.

[6]  J. Wallace,et al.  The bovine insulin-like growth factor (IGF) binding protein purified from conditioned medium requires the N-terminal tripeptide in IGF-1 for binding. , 1988, Biochemical and biophysical research communications.

[7]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[8]  K. Miyagawa,et al.  cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[9]  P. Cuevas,et al.  Hypotensive activity of fibroblast growth factor. , 1991, Science.

[10]  U. Stenman,et al.  Purification of placental protein PP12 from human amniotic fluid and its comparison with PP12 from placenta by immunological, physicochemical and somatomedin-binding properties. , 1987, Clinica chimica acta; international journal of clinical chemistry.

[11]  J. Dasch,et al.  Purification and characterization of transforming growth factor-beta 2.3 and -beta 1.2 heterodimers from bovine bone. , 1992, The Journal of biological chemistry.

[12]  D. Rifkin,et al.  Recent developments in the cell biology of basic fibroblast growth factor , 1989, The Journal of cell biology.

[13]  A. Balland,et al.  Isolation from human cerebrospinal fluid of a new insulin‐like growth factor‐binding protein with a selective affinity for IGF‐II , 1989, FEBS letters.

[14]  D. Gospodarowicz,et al.  Structural characterization and biological functions of fibroblast growth factor. , 1987, Endocrine reviews.

[15]  K. Matsumoto,et al.  Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  G. Sahagian,et al.  Biochemical evidence that the type II insulin-like growth factor receptor is identical to the cation-independent mannose 6-phosphate receptor. , 1988, The Journal of biological chemistry.

[17]  A. Reddi,et al.  Affinity of osteogenin, an extracellular bone matrix associated protein initiating bone differentiation, for concanavalin A. , 1989, Biochemical and biophysical research communications.

[18]  C. Fombrun,et al.  Matrix , 1979, Encyclopedic Dictionary of Archaeology.

[19]  J. Wergedal,et al.  Human skeletal growth factor: characterization of the mitogenic effect on bone cells in vitro. , 1982, Biochemistry.

[20]  W. Rutter,et al.  Insulin-like growth factor II receptor as a multifunctional binding protein , 1987, Nature.

[21]  B. Stadler,et al.  Production of hemopoietic growth factors by bone tissue and bone cells in culture , 1988, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  Darrell M. Wilson,et al.  Levels of insulin-like growth factors I and II in human cord blood. , 1983, The Journal of clinical endocrinology and metabolism.

[23]  M. Sporn,et al.  Some recent advances in the chemistry and biology of transforming growth factor-beta , 1987, The Journal of cell biology.

[24]  G. Rodan,et al.  Type-beta transforming growth factor inhibits proliferation and expression of alkaline phosphatase in murine osteoblast-like cells. , 1986, Biochemical and biophysical research communications.

[25]  A. Roberts,et al.  Membrane binding characteristics of two forms of transforming growth factor-beta. , 1987, The Journal of biological chemistry.

[26]  N. Savion,et al.  Basic fibroblast growth factor enhances the capacity of bone marrow cells to form bone‐like nodules in vitro , 1989, FEBS letters.

[27]  M. Sporn,et al.  Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro , 1987, The Journal of cell biology.

[28]  D. Baylink,et al.  Purification of a skeletal growth factor from human bone. , 1982, Biochemistry.

[29]  B. Olwin,et al.  Identification of the fibroblast growth factor receptor of Swiss 3T3 cells and mouse skeletal muscle myoblasts. , 1986, Biochemistry.

[30]  E. Canalis,et al.  Skeletal tissue and transforming growth factor β , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  S. Mohan,et al.  Human skeletal growth factor stimulates collagen synthesis and inhibits proliferation in a clonal osteoblast cell line (MC3T3‐E1) , 1986, Journal of cellular physiology.

[32]  F. D. Di Padova,et al.  Interleukin‐6 is produced by bone and modulated by parathyroid hormone , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  E. Canalis,et al.  Effects of fibroblast growth factors on deoxyribonucleic acid and collagen synthesis in rat parietal bone cells. , 1989, Endocrinology.

[34]  L. Demers,et al.  Ovariectomy selectively reduces the concentration of transforming growth factor beta in rat bone: implications for estrogen deficiency-associated bone loss. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Wergedal,et al.  Insulinlike growth factor II and transforming growth factor β regulate collagen expression in human osteoblastlike cells in vitro , 1991 .

[36]  G. Peters,et al.  Potential oncogene product related to growth factors , 1987, Nature.

[37]  Y. Ogawa,et al.  Transforming growth factor beta 1 systemically modulates granuloid, erythroid, lymphoid, and thrombocytic cells in mice. , 1992, Experimental hematology.

[38]  M. Urist,et al.  Bone cell differentiation and growth factors. , 1983, Science.

[39]  Christopher C. Binkert,et al.  Cloning, sequence analysis and expression of a cDNA encoding a novel insulin‐like growth factor binding protein (IGFBP‐2). , 1989, The EMBO journal.

[40]  E. Wagner,et al.  Bone and haematopoietic defects in mice lacking c-fos , 1992, Nature.

[41]  M. Hunkapiller,et al.  Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. V. Van Wyk,et al.  Sequence analysis of somatomedin-C: confirmation of identity with insulin-like growth factor I. , 1983, Endocrinology.

[43]  D. Baylink,et al.  In vitro evidence that bone formation may be coupled to resorption by release of mitogen(s) from resorbing bone. , 1987, Metabolism: clinical and experimental.

[44]  D. Baylink,et al.  Coupling factor. , 1982, Advances in Experimental Medicine and Biology.

[45]  R. Russell,et al.  An interleukin 1 like factor stimulates bone resorption in vitro , 1983, Nature.

[46]  R. Baxter,et al.  High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum. , 1989, The Journal of biological chemistry.

[47]  M. Rechler,et al.  The nature and regulation of the receptors for insulin-like growth factors. , 1985, Annual review of physiology.

[48]  H. Marquardt,et al.  Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor beta to the mature polypeptide , 1988, Molecular and cellular biology.

[49]  A. Roberts,et al.  Purification and properties of a type beta transforming growth factor from bovine kidney. , 1983, Biochemistry.

[50]  S. Mohan,et al.  Skeletal growth factor and other growth factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[51]  P. Campbell,et al.  Insulin‐Like growth factor binding protein (IGFBP) inhibits igf action on human osteosarcoma cells , 1991, Journal of cellular physiology.

[52]  M. Goldfarb,et al.  The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors , 1988, Molecular and cellular biology.

[53]  S. Mohan,et al.  Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: a potential local regulator of IGF action. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[54]  G. Mundy,et al.  Effects of human recombinant CSF‐GM and highly purified CSF‐1 on the formation of multinucleated cells with osteoclast characteristics in long‐term bone marrow cultures , 1986, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[55]  J. Schwander,et al.  Insulin-Like Growth Factor-Binding Protein , 1989, Definitions.

[56]  J. Graycar,et al.  Cartilage-inducing factor-B is a unique protein structurally and functionally related to transforming growth factor-beta. , 1987, The Journal of biological chemistry.

[57]  G. Wesolowski,et al.  Growth stimulation of rat calvaria osteoblastic cells by acidic fibroblast growth factor. , 1987, Endocrinology.

[58]  A. Reddi,et al.  Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[59]  E. Canalis,et al.  Isolation and characterization of insulin-like growth factor I (somatomedin-C) from cultures of fetal rat calvariae. , 1988, Endocrinology.

[60]  V. Rosen,et al.  Purification and molecular cloning of a novel group of BMPs and localization of BMP mRNA in developing bone. , 1989, Connective tissue research.

[61]  E. Canalis,et al.  Effects of basic fibroblast growth factor on bone formation in vitro. , 1988, The Journal of clinical investigation.

[62]  J. Massagué,et al.  Human platelet-derived transforming growth factor-beta stimulates parameters of bone growth in fetal rat calvariae. , 1986, Endocrinology.

[63]  S. Mohan,et al.  Interactions of growth factors present in bone matrix with bone cells: effects on DNA synthesis and alkaline phosphatase. , 1990, Growth factors.

[64]  P. Cuevas,et al.  Basic fibroblast growth factor (FGF) promotes cartilage repair in vivo. , 1988, Biochemical and biophysical research communications.

[65]  E. Canalis Insulin like growth factors and the local regulation of bone formation. , 1992, Bone.

[66]  G. Mundy,et al.  In vivo effects of human recombinant transforming growth factor β on bone turnover in normal mice , 1990 .

[67]  S. Mohan,et al.  Characterization of the receptor for insulin‐like growth factor II in bone cells , 1989, Journal of cellular physiology.

[68]  H. Oppermann,et al.  Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily. , 1990, The Journal of biological chemistry.

[69]  G. Rodan,et al.  Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3. , 1990, Endocrinology.

[70]  M. Hammerman,et al.  Insulin-like growth factors and aging. , 1987, Endocrinology and metabolism clinics of North America.

[71]  V. Rosen,et al.  Novel regulators of bone formation: molecular clones and activities. , 1988, Science.

[72]  R. Furlanetto,et al.  The type II insulin-like growth factor receptor does not mediate deoxyribonucleic acid synthesis in human fibroblasts. , 1987, The Journal of clinical endocrinology and metabolism.

[73]  T. C. B. STAMP,et al.  Mineral metabolism , 1974, Nature.

[74]  S. Mohan A simple and efficient scheme for the purification of insulin-like growth factor II from human bone matrix extract. , 1990, Growth factors.

[75]  R. Roth Structure of the receptor for insulin-like growth factor II: the puzzle amplified. , 1988, Science.

[76]  D. Clemmons,et al.  An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[77]  Mark E. Bolander,et al.  Regulation of Fracture Repair by Growth Factors , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[78]  C. Osborne,et al.  Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. , 1989, The Journal of clinical investigation.

[79]  J. Wergedal,et al.  Increases in number and size of osteoclasts in response to calcium or phosphorus deficiency in the rat. , 1975, Endocrinology.

[80]  M. Ranke,et al.  Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I. , 1989, Endocrinology.

[81]  W. Hazzard,et al.  Principles of geriatric medicine , 1985 .

[82]  E. Canalis,et al.  Parathyroid hormone modulates transforming growth factor beta activity and binding in osteoblast-enriched cell cultures from fetal rat parietal bone. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[83]  R. Ross,et al.  The biology of platelet-derived growth factor , 1986, Cell.

[84]  E. Drier,et al.  OP‐1 cDNA encodes an osteogenic protein in the TGF‐beta family. , 1990, The EMBO journal.

[85]  M. O’Connor-McCourt,et al.  Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin. , 1987, The Journal of biological chemistry.

[86]  V. Rosen,et al.  Novel regulators of bone formation: molecular clones and activities. , 1988 .

[87]  D. Baylink,et al.  Postmenopausal osteoporosis: proposed roles of defective coupling and estrogen deficiency. , 1981, Metabolic bone disease & related research.

[88]  D. Andress,et al.  Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. , 1992, The Journal of biological chemistry.

[89]  E. Canalis,et al.  Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. , 1987, The Journal of biological chemistry.

[90]  S. Mohan,et al.  Estradiol stimulates in vitro the secretion of insulin-like growth factors by the clonal osteoblastic cell line, UMR106. , 1989, Biochemical and biophysical research communications.

[91]  S. Mohan,et al.  Chemical and biological characterization of low-molecular-weight human skeletal growth factor. , 1986, Biochimica et biophysica acta.

[92]  B. Riggs,et al.  Modulation of Transforming Growth Factor-β Production in Normal Human Osteoblast-Like Cells by 17β-Estradiol and Parathyroid Hormone , 1991 .

[93]  K. Nakashima,et al.  Reduction of basic fibroblasts growth factor receptor is coupled with terminal differentiation of chondrocytes. , 1991, The Journal of biological chemistry.

[94]  S. Mohan,et al.  Parathyroid hormone stimulates release of insulin-like growth factor-I (IGF-I) and IGF-II from neonatal mouse calvaria in organ culture. , 1989, Endocrinology.

[95]  P. ten Dijke,et al.  Identification of another member of the transforming growth factor type beta gene family. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[96]  R. Hintz,et al.  Somatomedin Receptors: Structure, Function, and Regulation , 1986 .

[97]  K. Hall,et al.  The somatomedin-binding protein isolated from a human hepatoma cell line is identical to the human amniotic fluid somatomedin-binding protein. , 1985, Biochemical and biophysical research communications.

[98]  D. Gospodarowicz Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth , 1974, Nature.

[99]  K. Thomas,et al.  Purification and characterization of acidic fibroblast growth factor from bovine brain. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[100]  S. Mohan,et al.  Characterization of mitogenic activities extracted from bovine bone matrix. , 1986, Bone.

[101]  G. Howard,et al.  Parathyroid hormone stimulates bone formation and resorption in organ culture: evidence for a coupling mechanism. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[102]  J. Wergedal,et al.  Differentiation of normal human bone cells by transforming growth factor-beta and 1,25(OH)2 vitamin D3. , 1992, Metabolism: clinical and experimental.

[103]  J. McPherson,et al.  Cartilage-inducing factor-A. Apparent identity to transforming growth factor-beta. , 1986, The Journal of biological chemistry.

[104]  D. Donoghue,et al.  Structure and function of platelet-derived growth factor (PDGF) and related proteins. , 1989, Biochimica et biophysica acta.

[105]  J. Massagué,et al.  Multiple type-beta transforming growth factors and their receptors. , 1987, Journal of cellular physiology. Supplement.

[106]  M. Klagsbrun,et al.  Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose. , 1986, The Journal of biological chemistry.

[107]  P. Segarini,et al.  Purification and characterization of a unique osteoinductive factor from bovine bone. , 1989, The Journal of biological chemistry.

[108]  Y. Ohmori,et al.  Human purified interleukin‐1 inhibits DNA synthesis and cell growth of osteoblastic cell line (MC3T3‐E1), but enhances alkaline phosphatase activity in the cells , 1986, FEBS letters.

[109]  E. Froesch,et al.  Release of insulin-like growth factor carrier proteins by osteoblasts: stimulation by estradiol and growth hormone. , 1989, Biochemical and biophysical research communications.

[110]  G. Mundy,et al.  Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[111]  A. Ullrich,et al.  A single receptor binds both insulin-like growth factor II and mannose-6-phosphate. , 1988, Science.

[112]  William C. Smith,et al.  Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos , 1992, Cell.

[113]  R. Palmiter,et al.  Growth enhancement of transgenic mice expressing human insulin-like growth factor I. , 1988, Endocrinology.

[114]  D. Gospodarowicz,et al.  Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor beta. , 1988, Endocrinology.

[115]  G. Wesolowski,et al.  Opposing effects of fibroblast growth factor and pertussis toxin on alkaline phosphatase, osteopontin, osteocalcin, and type I collagen mRNA levels in ROS 17/2.8 cells. , 1989, The Journal of biological chemistry.

[116]  M. Hayman,et al.  Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[117]  G. Ooi,et al.  The biological and structural characterization of specific serum binding proteins for the insulin-like growth factors. , 1988, The Journal of endocrinology.

[118]  L. Donahue,et al.  The 24/25-kDa serum insulin-like growth factor-binding protein is increased in elderly women with hip and spine fractures. , 1992, The Journal of clinical endocrinology and metabolism.

[119]  R. Kamen,et al.  The human hematopoietic colony-stimulating factors. , 1987, Science.

[120]  K. Mitchell,et al.  Macrophage-derived growth factor for osteoblast-like cells and chondrocytes. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[121]  S. Mohan,et al.  Vitamin D deficiency causes a selective reduction in deposition of transforming growth factor beta in rat bone: possible mechanism for impaired osteoinduction. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[122]  S. Mohan,et al.  Development of valid methods to measure insulin-like growth factors-I and -II in bone cell-conditioned medium. , 1990, Endocrinology.

[123]  D. Rowe,et al.  Insulin-like growth factor I regulates type I procollagen messenger ribonucleic acid steady state levels in bone of rats. , 1989, Endocrinology.

[124]  N. Ling,et al.  Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[125]  S. Mohan,et al.  Heterogeneity of latent transforming growth factor-beta isolated from bone matrix proteins. , 1990, Endocrinology.

[126]  S. Ljunghall,et al.  Insulin-like growth factor I stimulates bone turnover in osteoporosis , 1992, The Lancet.

[127]  A. Moses,et al.  Increased levels of multiplication-stimulating activity, an insulin-like growth factor, in fetal rat serum. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[128]  D. Gospodarowicz,et al.  The identification and partial characterization of the fibroblast growth factor receptor of baby hamster kidney cells. , 1985, The Journal of biological chemistry.

[129]  A. Reddi,et al.  Osteogenin, a bone morphogenetic protein, adsorbed on porous hydroxyapatite substrata, induces rapid bone differentiation in calvarial defects of adult primates. , 1992, Plastic and reconstructive surgery.

[130]  Sporn,et al.  Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. , 1988, The Journal of biological chemistry.

[131]  J. Irminger,et al.  Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms tumors: expression at the mRNA and protein level. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[132]  R. Voutilainen,et al.  Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. , 1988, Endocrinology.

[133]  A. Reddi,et al.  Dissociative extraction and partial purification of osteogenin, a bone inductive protein, from rat tooth matrix by heparin affinity chromatography. , 1988, Biochemical and biophysical research communications.

[134]  M. Sporn,et al.  Purification and initial characterization of a type beta transforming growth factor from human placenta. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[135]  D. Moscatelli,et al.  High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells , 1987, Journal of cellular physiology.

[136]  E. Rinderknecht,et al.  Amino-terminal sequences of two polypeptides from human serum with nonsuppressible insulin-like and cell-growth-promoting activities: evidence for structural homology with insulin B chain. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[137]  B. Olwin,et al.  Identification of a cysteine-rich receptor for fibroblast growth factors , 1992, Molecular and cellular biology.

[138]  J. Lian,et al.  Effects of bone associated growth factors on DNA, collagen and osteocalcin synthesis in cultured fetal rat calvariae. , 1988, Bone.

[139]  J. Rubin,et al.  Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. , 1989, Science.

[140]  M. Sporn,et al.  Complementary deoxyribonucleic acid cloning of a messenger ribonucleic acid encoding transforming growth factor beta 4 from chicken embryo chondrocytes. , 1988, Molecular endocrinology.

[141]  R. Baxter,et al.  Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. , 1988, Biochemical and biophysical research communications.

[142]  E. Froesch,et al.  Insulin-like growth factors/somatomedins: structure, secretion, biological actions and physiological role. , 1986, Hormone research.

[143]  G. Howard,et al.  Extracts of bone contain a potent regulator of bone formation. , 1982, Biochimica et biophysica acta.

[144]  S. Handwerger,et al.  Developmental patterns of insulin-like growth factor-I and -II synthesis and regulation in rat fibroblasts , 1983, Nature.

[145]  D. Rosen,et al.  Purification and characterization of two cartilage-inducing factors from bovine demineralized bone. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[146]  Y. Ohmori,et al.  Spontaneous production of interleukin-1-like cytokine from a mouse osteoblastic cell line (MC3T3-E1). , 1985, Biochemical and biophysical research communications.

[147]  S. Mohan,et al.  Beta 2-microglobulin is not a bone cell mitogen. , 1989, Endocrinology.

[148]  S. Mohan,et al.  Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone. , 1991, Biochemical and biophysical research communications.

[149]  W. Wood,et al.  Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein. , 1988, Molecular endocrinology.

[150]  E. Mackie,et al.  Stimulation of bone formation in vivo by transforming growth factor-beta: remodeling of woven bone and lack of inhibition by indomethacin. , 1990, Bone.

[151]  C Collins,et al.  Insulin‐like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. , 1986, The EMBO journal.

[152]  S. Mohan,et al.  Comparison of the biological actions of TGF beta‐1 and TGF beta‐2: Differential activity in endothelial cells , 1988, Journal of cellular physiology.

[153]  J. Heath,et al.  Developmentally regulated expression of insulin-like growth factors by differentiated murine teratocarcinomas and extraembryonic mesoderm. , 1986, Journal of embryology and experimental morphology.

[154]  A. König,et al.  Tumor necrosis factor α and interleukin‐1 stimulate bone resorption in vivo as measured by urinary [3H]tetracycline excretion from prelabeled mice , 1988 .

[155]  G. Smith,et al.  Inhibition of biological activity of multiplication-stimulating activity by binding to its carrier protein. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[156]  H. Armelin Pituitary extracts and steroid hormones in the control of 3T3 cell growth. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[157]  I. Nishimoto,et al.  Evidence that type II insulin-like growth factor receptor is coupled to calcium gating system. , 1988, Biochemical and biophysical research communications.

[158]  S. Mohan,et al.  Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone cells. , 1990, The Journal of clinical endocrinology and metabolism.

[159]  A. Lindahl,et al.  Effects of local administration of GH and IGF-1 on longitudinal bone growth in rats. , 1986, The American journal of physiology.

[160]  M. Czech,et al.  Purification and amino-terminal sequence of an insulin-like growth factor-binding protein secreted by rat liver BRL-3A cells. , 1986, The Journal of biological chemistry.

[161]  A. Efstratiadis,et al.  Parental imprinting of the mouse insulin-like growth factor II gene , 1991, Cell.

[162]  V. Rosen,et al.  Purification and characterization of other distinct bone-inducing factors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[163]  J. Sussenbach The gene structure of the insulin-like growth factor family. , 1989, Progress in growth factor research.

[164]  S. Mohan,et al.  Skeletal growth factor is produced by human osteoblast-like cells in culture. , 1986, Biochimica et biophysica acta.

[165]  D. Birnbaum,et al.  Characterization of the HST-related FGF.6 gene, a new member of the fibroblast growth factor gene family. , 1989, Oncogene.

[166]  G. Proetzel,et al.  Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.

[167]  E. Chen,et al.  The murine transforming growth factor-beta precursor. , 1986, The Journal of biological chemistry.

[168]  D. B. Evans,et al.  The effects of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) on human osteoblast-like cells. , 1989, Biochemical and biophysical research communications.

[169]  M E Bolander,et al.  Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur , 1990, The Journal of cell biology.

[170]  G. Rodan,et al.  Type-β transforming growth factor inhibits proliferation and expression of alkaline phosphatase in murine osteoblast-like cells , 1986 .

[171]  Birgitta,et al.  An antibody that blocks insulin-like growth factor (IGF) binding to the type II IGF receptor is neither an agonist nor an inhibitor of IGF-stimulated biologic responses in L6 myoblasts. , 1987, The Journal of biological chemistry.

[172]  S. Mohan,et al.  Insulin-like growth factors I and II are present in the skeletal tissues of ten vertebrates. , 1990, Metabolism: clinical and experimental.

[173]  M. Urist Bone: Formation by Autoinduction , 1965, Science.

[174]  E. Canalis,et al.  Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone. , 1989, Endocrinology.

[175]  J. Puzas,et al.  Effects of transforming growth factor-beta on matrix synthesis by chick growth plate chondrocytes. , 1988, Endocrinology.

[176]  P. Schnegelsberg,et al.  Osteogenic protein-2. A new member of the transforming growth factor-beta superfamily expressed early in embryogenesis. , 1992, The Journal of biological chemistry.

[177]  G. Howard,et al.  In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats. , 1991, Bone.

[178]  E. Canalis,et al.  Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. , 1988, Endocrinology.

[179]  P. Rotwein,et al.  Coordinate expression of insulin-like growth factor II and its receptor during muscle differentiation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[180]  R. Derynck,et al.  Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[181]  S. Bell,et al.  N-terminal amino acid sequence of human pregnancy-associated endometrial alpha 1-globulin, an endometrial insulin-like growth factor (IGF) binding protein--evidence for two small molecular weight IGF binding proteins. , 1988, Endocrinology.

[182]  H. Antoniades,et al.  Platelet-derived growth factor stimulates bone resorption via a prostaglandin-mediated mechanism. , 1982, Endocrinology.

[183]  D. B. Evans,et al.  Recombinant human [Cys281]insulin-like growth factor-binding protein 2 inhibits both basal and insulin-like growth factor I-stimulated proliferation and collagen synthesis in fetal rat calvariae. , 1991, The Journal of biological chemistry.

[184]  D. Moscatelli,et al.  Mr 25,000 heparin-binding protein from guinea pig brain is a high molecular weight form of basic fibroblast growth factor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[185]  N. Copeland,et al.  The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGFβ superfamily , 1992, Cell.

[186]  E. Froesch,et al.  Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.